Actively Recruiting

Age: 18Years +
All Genders
NCT07073079

A Study to Assess the Effectiveness of Second-Line Therapy of Upadacitinib and Risankizumab in Adult Participants With Crohn's Disease in a Real-World Setting

Led by AbbVie · Updated on 2026-02-24

250

Participants Needed

23

Research Sites

124 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Crohn's disease (CD) is an incurable chronic inflammatory disorder of the gastrointestinal tract. This study will evaluate the second line effectiveness of upadacitinib and risankizumab in Crohn's Disease (CD) in a real-world setting. Upadacitinib and risankizumab are approved drugs for treating CD. Approximately 250 participants who are prescribed upadacitinib or risankizumab by their physician in accordance with local label will be enrolled in 25 sites across Italy. Participants will receive upadacitinib or risankizumab as prescribed by their physician according to their routine clinical practice and local label. Participants will be followed for up to 18 months. No additional burden for participants in this trial is expected.

CONDITIONS

Official Title

A Study to Assess the Effectiveness of Second-Line Therapy of Upadacitinib and Risankizumab in Adult Participants With Crohn's Disease in a Real-World Setting

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults diagnosed with moderate-to-severe Crohn's Disease confirmed by clinical or endoscopic/histological measures
  • Previously treated with Tumor Necrosis Factor inhibitor as first-line therapy for at least 6 months
  • Clinical records available for the previous 2 years or since start of first-line therapy
Not Eligible

You will not qualify if you...

  • Any condition listed as a warning or contraindication in the approved upadacitinib or risankizumab labels
  • Previous use of upadacitinib, risankizumab, or any approved or investigational non-TNF biologic Disease Modifying Antirheumatic Drug for Crohn's Disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 23 locations

1

Ospedale Specializzato In Gastroenterologia Saverio De Bellis /ID# 275706

Castellana Grotte, Bari, Italy, 70013

Actively Recruiting

2

Azienda Ospedaliero Universitaria di Cagliari - P.O. Duilio Casula /ID# 275216

Monserrato, Cagliari, Italy, 09042

Actively Recruiting

3

Fondazione di Religione e di Culto Casa Sollievo della Sofferenza /ID# 275669

San Giovanni Rotondo, Foggia, Italy, 71013

Actively Recruiting

4

Ospedale San Martino /ID# 274529

Genoa, Genova, Italy, 16132

Actively Recruiting

5

IRCCS Istituto Clinico Humanitas /ID# 274489

Rozzano, Lombardy, Italy, 20089

Actively Recruiting

6

IRCCS Ospedale San Raffaele /ID# 274458

Milan, Milano, Italy, 20132

Actively Recruiting

7

Fondazione IRCCS San Gerardo dei Tintori - Ospedale San Gerardo /ID# 274682

Monza, Monza E Brianza, Italy, 20052

Actively Recruiting

8

Azienda Ospedaliera Universitaria Federico II /ID# 274570

Naples, Napoli, Italy, 80131

Actively Recruiting

9

Azienda Ospedaliera Universitaria Luigi Vanvitelli /ID# 274788

Naples, Napoli, Italy, 80138

Actively Recruiting

10

A.O.U. CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO - Ospedale Molinette /ID# 274461

Turin, Piedmont, Italy, 10126

Actively Recruiting

11

Azienda Ospedaliera Universitaria Policlinico Tor Vergata /ID# 274654

Rome, Roma, Italy, 00133

Actively Recruiting

12

Ospedale Sandro Pertini /ID# 275023

Rome, Roma, Italy, 00157

Actively Recruiting

13

Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Universita Cattolica /ID# 274530

Rome, Roma, Italy, 00168

Actively Recruiting

14

A.O. Ordine Mauriziano di Torino /ID# 274459

Turin, Torino, Italy, 10128

Actively Recruiting

15

IRCCS Ospedale Sacro Cuore Don Calabria /ID# 274462

Negrar, Verona, Italy, 37024

Actively Recruiting

16

A.O.U. Consorziale Policlinico di Bari /ID# 274662

Bari, Italy, 70124

Actively Recruiting

17

IRCCS AOU di Bologna Policlinico Sant Orsola Malpighi /ID# 275161

Bologna, Italy, 40138

Actively Recruiting

18

AOU Policlinico G. Rodolico - San Marco /ID# 274909

Catania, Italy, 95123

Actively Recruiting

19

Azienda Ospedaliera di Catanzaro Pugliese Ciaccio /ID# 274571

Catanzaro, Italy, 88100

Actively Recruiting

20

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico /ID# 274618

Milan, Italy, 20122

Actively Recruiting

21

Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello /ID# 274964

Palermo, Italy, 90146

Actively Recruiting

22

Fondazione Policlinico Universitario Campus Bio-Medico /ID# 274488

Roma, Italy, 00128

Actively Recruiting

23

Fatebenefratelli Isola Tiberina - Gemelli Isola /ID# 274966

Roma, Italy, 00186

Actively Recruiting

Loading map...

Research Team

C

Caterina Golotta

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Study to Assess the Effectiveness of Second-Line Therapy of Upadacitinib and Risankizumab in Adult Participants With Crohn's Disease in a Real-World Setting | DecenTrialz